Webinars/Videos

In this video, we cover the latest information obtained on Lp(a) from this year’s ACC.

First published: May 30, 2023  

In this talk, Prof. Lale Tokyozoglu comprehensively summarizes the latest research and clinical updates in ASCVD and Lipidology from the last year.

Prof. Lale Tokyozoglu

First published: March 27, 2023  

In this KOL master class on demand video Prof. Samer Ellahham discusses the secondary prevention of acute coronary syndrome (ACS). He is joined by Prof. Hani Sabbour for a peer-to-peer discussion and to answer audience questions.

This interactive webinar is designed for health care professionals (cardiologists, endocrinologists, lipidologists, neurologists) who are interested in learning more on the latest research, treatment, and clinical management of patients with acute coronary syndrome.

Prof. Samer Ellahham, Prof. Hani Sabbour

First published: February 28, 2023  

This animated video highlights the importance of early identification and treatment of CVD risk factors in women.

Susan L. Ivey, Hattie Rees Hanley, Catrina Taylor, Eveline Stock, Nirali Vora, Jenny Woo, Sara Johnson, C. Noel Bairy Merz, Right Care Women's Cardiovascular Writing Group

First published: February 9, 2023  

In the first half of this two part webinar, listen to Prof. Christopher Cannon summarizing the highlights from AHA Scientific Session 2022. In the second half, Prof. Cannon is joined by Prof. Stephen Nicholls discussing the important findings from AHA and answering audience questions.

Prof. Christopher Cannon and Prof. Stephen Nicholls

First published: December 7, 2022  

Watch part one of the ESC Highlights Video. In this video Prof. Lale Tokgözoğlu summarizes some of the exciting findings that were presented in ESC 2022.

Prof. Christopher P. Cannon and Prof. S. Lale Tokgözoğlu

First published: November 1, 2022  

Watch part two of the ESC Highlights Video wherein Prof. Christopher Cannon and Prof. Lale Tokgözoğlu discuss results of some exciting trials highlighting the significance of Lp(a), PCSK9 inhibitors, patient adherence and compliance.

Prof. Christopher P. Cannon and Prof. S. Lale Tokgözoğlu

First published: November 1, 2022  

This EAS highlights video provides insights into future prospects for the prevention and treatment of dyslipidemia and ASCVD through novel avenues.

First published: August 16, 2022  

In this KOL masterclass on demand video, Prof. Stephen Nicholls will discuss the impact of intensive lipid lowering strategies (statins, evolocumab, alirocumab) on plaque phenotype and progression.

This masterclass on-demand video is designed for health care professionals (cardiologists, lipidologists, diabetes specialists, neurologists) who are interested in learning more on the results of the latest clinical trials (GLAGOV, HUYGENS, PACMAN-AMI) on coronary disease.

Prof. Stephen Nicholls

First published: July 7, 2022  

This ACC highlights video provides insights into novel strategies to lower the levels of triglycerides to reduce triglyceride-associated complications.

First published: June 30, 2022  

In this KOL master class on demand video Prof. Maciej Banach discusses the prevalence and current understanding of statin Intolerance which remains a public health problem currently. He is joined by Prof. Christopher Cannon for a peer-to-peer discussion and to answer audience questions.

This interactive webinar is designed for health care professionals (cardiologists, endocrinologists, lipidologists, neurologists) who are interested in learning more on the latest research, treatment, and clinical management of patients with statin intolerance.

Click here to download the unanswered questions from this webinar.

Prof. Maciej Banach, Prof. Christopher Cannon

First published: June 6, 2022  

In this KOL masterclass on demand video, Prof. Sameer Ellaham will discuss the role of lipoprotein (a) in cardiovascular disease risk and possible ways to manage and treat Lp(a) levels in patients.

This masterclass on-demand video is designed for heath care professionals (cardiologists, lipidologists, diabetes specialists, neurologists) who are interested in learning more on the latest research, treatment, and clinical management of patients with a risk of ASCVD and having an elevated level of Lp(a).

Prof. Sameer Ellaham

First published: April 26, 2022